Halozyme Therapeutics
HALO
#2170
Rank
C$10.34 B
Marketcap
$81.29
Share price
-1.40%
Change (1 day)
67.54%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): C$0.64 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$0.94 Billion. In 2023 the company made an earning of C$0.49 Billion, an increase over its 2022 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.64 B30.76%
2023 C$0.49 B39.94%
2022 C$0.35 B0.16%
2021 C$0.35 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$87.72 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$45.9 Million-52.86%
2014 -C$97.36 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$76.26 Million169.94%
2011 -C$28.25 Million-63.44%
2010 -C$77.26 Million-7.19%
2009 -C$83.24 Million15.91%
2008 -C$71.82 Million83.89%
2007 -C$39.06 Million78.1%
2006 -C$21.93 Million16%
2005 -C$18.91 Million45.24%
2004 -C$13.02 Million682.42%
2003 -C$1.67 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$35.64 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.45 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.23 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.88 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.54 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
C$24.83 B 3,533.05%๐Ÿ‡บ๐Ÿ‡ธ USA